CD8A and glioblastoma: We primed naive CD8+ T cells from two HLA-A24+ HDs separately with RCAN1-422-32 in vitro, followed by recall with RCAN1-4pos SF10360 GBM cells (Fig. 4A, Supplementary Fig. 8B).